Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | PTGFR | P43088 | 3/20 | 0.32 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.32 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.32 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4449601 | 1.00 | ABCB1 (0.34) | ABCB1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL4449606 | 1.00 | ABCB1 (0.34) | ABCB1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL4448187 | 1.00 | ABCB1 (0.34) | ABCB1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1398010 | 1.00 | ABCB1 (0.34) | ABCB1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL4451943 | 1.00 | ABCB1 (0.34) | ABCB1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL5079745 | 1.00 | ABCB1 (0.34) | ABCB1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL4448184 | 1.00 | ABCB1 (0.34) | ABCB1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1398009 | 1.00 | ABCB1 (0.34) | ABCB1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL4447911 | 1.00 | ABCB1 (0.34) | ABCB1MEN1KMT2ALMNACYP1A2 | |
| SCHEMBL1618846 | 1.00 | ABCB1 (0.34) | ABCB1MEN1KMT2ALMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036530-A1 | Crystalline acid of lipoxin A4 analogs and method of making | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-02-05 | — | — | US | claimed |
| US-20080182901-A1 | Crystalline acid of lipoxin A4 analogs and method of making | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-07-31 | — | — | US | claimed |
| US-20090036530-A1 | Crystalline acid of lipoxin A4 analogs and method of making | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-02-05 | — | — | US | disclosed |
| US-20080182901-A1 | Crystalline acid of lipoxin A4 analogs and method of making | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036530-A1 | Crystalline acid of lipoxin A4 analogs and method of making | LTA4H, LTB4R2, ALOX5 | ABCB1 4643/4885MEN1 4296/4885KMT2A 4792/4885 |
| US-20080182901-A1 | Crystalline acid of lipoxin A4 analogs and method of making | LTA4H, LTB4R2, ALOX5 | ABCB1 4643/4885MEN1 4296/4885KMT2A 4792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.